Condition 101 About Acromegaloid Facial Appearance Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Acromegaloid Facial Appearance Syndrome

View All Doctors

Latest Advances On Acromegaloid Facial Appearance Syndrome

  • Condition: Growth Hormone (GH)-Secreting Adenomas with Cavernous Sinus (CS) Invasion
  • Journal: Neurocirugia (English Edition)
  • Treatment Used: Endoscopic Endonasal Lateral Transellar Approach
  • Number of Patients: 94
  • Published —
This study presented experience with an endoscopic endonasal lateral transellar approach for the treatment of patients with growth hormone-secreting adenomas with cavernous sinus (CS) invasion.
  • Journal: Genes
  • Published —
Genotype-Phenotype Correlations in 208 Individuals with Coffin-Siris Syndrome.
View All Latest Advances

Clinical Trials For Acromegaloid Facial Appearance Syndrome

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 52
  • Start Date: April 2021
A Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects With Acromegaly Treated With Long-acting Somatostatin Receptor Ligands (PATHFNDR 1)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: January 4, 2021
An Open Label, Randomized, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx, an Antisense Inhibitor of the Growth Hormone Receptor, Administered Monthly as Monotherapy in Patients With Acromegaly
View All Clinical Trials